Literature DB >> 20880840

FoxOs function synergistically to promote glucose production.

Rebecca A Haeusler1, Klaus H Kaestner, Domenico Accili.   

Abstract

Hepatic glucose production (HGP) plays a vital role in maintaining the supply of glucose to the body, and transcription factor FoxO1 is known to confer hormone responsiveness onto HGP. Mice with a liver-specific FoxO1 deletion (L-FoxO1) show reduced HGP and reduced expression of glucose production genes. To determine the contribution of additional transcription factors to HGP, we created double and triple liver-specific knock-outs lacking FoxO1, FoxO3, and FoxO4 or the related protein FoxA2. We show that, when compared with single knock-out of FoxO1, triple ablation of FoxO genes causes more pronounced fasting hypoglycemia, increased glucose tolerance, and enhanced insulin sensitivity, with decreased plasma insulin levels. In contrast, combined ablation of FoxO1 and FoxA2 phenocopied the single knock-out of FoxO1. These data indicate that FoxOs work in concert to regulate multiple aspects of hepatic glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880840      PMCID: PMC2975147          DOI: 10.1074/jbc.C110.175851

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

Authors:  Christian Wolfrum; Esra Asilmaz; Edlira Luca; Jeffrey M Friedman; Markus Stoffel
Journal:  Nature       Date:  2004-12-23       Impact factor: 49.962

2.  FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

Authors:  Ji-Hye Paik; Ramya Kollipara; Gerald Chu; Hongkai Ji; Yonghong Xiao; Zhihu Ding; Lili Miao; Zuzana Tothova; James W Horner; Daniel R Carrasco; Shan Jiang; D Gary Gilliland; Lynda Chin; Wing H Wong; Diego H Castrillon; Ronald A DePinho
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

Review 3.  FOXO animal models reveal a variety of diverse roles for FOXO transcription factors.

Authors:  K C Arden
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

4.  The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.

Authors:  Seung-Hoi Koo; Lawrence Flechner; Ling Qi; Xinmin Zhang; Robert A Screaton; Shawn Jeffries; Susan Hedrick; Wu Xu; Fayçal Boussouar; Paul Brindle; Hiroshi Takemori; Marc Montminy
Journal:  Nature       Date:  2005-09-07       Impact factor: 49.962

5.  The role of hepatic insulin receptors in the regulation of glucose production.

Authors:  Alan D Cherrington
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 6.  Glucose homeostasis in the newborn.

Authors:  Robert Hume; Ann Burchell; Fiona L R Williams; Daisy K M Koh
Journal:  Early Hum Dev       Date:  2004-11-19       Impact factor: 2.079

7.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.

Authors:  Michihiro Matsumoto; Alessandro Pocai; Luciano Rossetti; Ronald A Depinho; Domenico Accili
Journal:  Cell Metab       Date:  2007-09       Impact factor: 27.287

8.  FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.

Authors:  Wenwei Zhang; Sandip Patil; Balwant Chauhan; Shaodong Guo; David R Powell; Jamie Le; Angelos Klotsas; Ryan Matika; Xiangshan Xiao; Roberta Franks; Kim A Heidenreich; Mini P Sajan; Robert V Farese; Donna Beer Stolz; Patrick Tso; Seung-Hoi Koo; Marc Montminy; Terry G Unterman
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

9.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.

Authors:  Xiaocheng C Dong; Kyle D Copps; Shaodong Guo; Yedan Li; Ramya Kollipara; Ronald A DePinho; Morris F White
Journal:  Cell Metab       Date:  2008-07       Impact factor: 27.287

10.  Farnesoid X receptor is essential for normal glucose homeostasis.

Authors:  Ke Ma; Pradip K Saha; Lawrence Chan; David D Moore
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

View more
  89 in total

1.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.

Authors:  Kebin Zhang; Ling Li; Yajuan Qi; Xiaoping Zhu; Boyi Gan; Ronald A DePinho; Travis Averitt; Shaodong Guo
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.

Authors:  Kyoichiro Tsuchiya; Jun Tanaka; Yu Shuiqing; Carrie L Welch; Ronald A DePinho; Ira Tabas; Alan R Tall; Ira J Goldberg; Domenico Accili
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

3.  Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c.

Authors:  Min Wan; Karla F Leavens; Danish Saleh; Rachael M Easton; David A Guertin; Timothy R Peterson; Klaus H Kaestner; David M Sabatini; Morris J Birnbaum
Journal:  Cell Metab       Date:  2011-10-05       Impact factor: 27.287

4.  The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cells.

Authors:  Olivier Briand; Audrey Helleboid-Chapman; Maheul Ploton; Nathalie Hennuyer; Rodolphe Carpentier; François Pattou; Brigitte Vandewalle; Ericka Moerman; Valery Gmyr; Julie Kerr-Conte; Jérôme Eeckhoute; Bart Staels; Philippe Lefebvre
Journal:  Mol Endocrinol       Date:  2012-02-02

5.  Physical exercise reduces pyruvate carboxylase (PCB) and contributes to hyperglycemia reduction in obese mice.

Authors:  Vitor Rosetto Muñoz; Rafael Calais Gaspar; Barbara Moreira Crisol; Guilherme Pedron Formigari; Marcella Ramos Sant'Ana; José Diego Botezelli; Rodrigo Stellzer Gaspar; Adelino S R da Silva; Dennys Esper Cintra; Leandro Pereira de Moura; Eduardo Rochete Ropelle; José Rodrigo Pauli
Journal:  J Physiol Sci       Date:  2017-07-14       Impact factor: 2.781

6.  FOXO transcription factors in non-alcoholic fatty liver disease.

Authors:  X Charlie Dong
Journal:  Liver Res       Date:  2017-09

Review 7.  FoxO6 in glucose metabolism (FoxO6).

Authors:  Dae Hyun Kim; Ting Zhang; Sojin Lee; H Henry Dong
Journal:  J Diabetes       Date:  2013-05-28       Impact factor: 4.006

Review 8.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

Review 9.  Fox transcription factors: from development to disease.

Authors:  Maria L Golson; Klaus H Kaestner
Journal:  Development       Date:  2016-12-15       Impact factor: 6.868

10.  Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice.

Authors:  Kyoichiro Tsuchiya; Marit Westerterp; Andrew J Murphy; Vidya Subramanian; Anthony W Ferrante; Alan R Tall; Domenico Accili
Journal:  Circ Res       Date:  2013-02-18       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.